My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 2 results for

GO
Search Filters: Delaware cancel Social and Behavioral Health cancel Maine cancel Indiana cancel Policy cancel

ASTHO Policy Watch 2022: Mental Health

Blog,
Health Policy Update,
Health Equity,
At-Risk Populations,
Rural Health,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
Suicide Prevention,
Policy,
State Health Policy,
Alabama,
Arizona,
Arkansas,
Colorado,
Delaware,
Florida,
Hawaii,
Illinois,
Indiana,
Kentucky,
Maine,
Maryland,
Minnesota,
New Jersey,
Ohio,
Oregon,
Rhode Island,
South Carolina,
Tennessee,
Texas,
Virginia,
Washington,
Washington, D.C.,
West Virginia,
Maggie Davis,
LGBTQ+

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...